Discover how Novo Nordisk's pipeline is being restructured to refocus its efforts on high-growth areas like diabetes and ...
The Trump administration is negotiating an agreement with pharmaceutical companies Novo Nordisk and Eli Lilly to offer some ...
The Trump administration is nearing deals with drugmakers Eli Lilly and Novo Nordisk to offer some of their obesity drugs to consumers for as low as $149 per month, according to two people familiar ...
The boss of the Wegovy firm linked its reduced guidance to the market for weight-loss treatments being ‘more competitive than ...
The bank's lead analyst recognizes the importance of getting in early with potentially game-changing drug development.
WISN 12 News on MSN
Trump administration nears deal to offer obesity drugs for $149 a month
The Trump administration is nearing deals with drugmakers Eli Lilly and Novo Nordisk to offer some of their obesity drugs to ...
Healthy people who suffer traumatic spinal injuries are at significantly greater risk for long-term chronic health conditions ...
A new NBC News poll found that 63% of registered voters believe Trump is failing to live up to expectations on the economy, ...
U.S. stock indexes were poised for a muted open on Wednesday, as investors retreated from AI-linked stocks for ...
Pfizer and Novo Nordisk continue to fight for ownership of obesity startup Metsera; CDER Director George Tidmarsh leaves his ...
The FDA in September approved elamipretide (Forzinity) as the first treatment for the ultra-rare Barth syndrome despite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback